Autologous bone marrow transplantation with immunotoxin purged marrow for multiple myeloma. Long term results in 14 patients with advanced disease.
Gobbi
M
M
Istituto di Ematologia, Seràgnoli, Università d Bologna, Italy.
Tazzari
P L
PL
Cavo
M
M
Tassi
C
C
Grimaldi
M
M
Meloni
G
G
Di Nucci
G
G
Vignetti
M
M
Bolognesi
A
A
Stirpe
F
F
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001853:Bone Marrow / Q000187:drug effects / Q000473:pathology; D016026:Bone Marrow Transplantation; D002478:Cells, Cultured; D003131:Combined Modality Therapy; D005069:Evaluation Studies as Topic; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D000922:Immunotoxins / Q000494:pharmacology*; D007370:Interferon Type I / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000473:pathology / Q000601:surgery* / Q000628:therapy; D014411:Neoplastic Stem Cells / Q000187:drug effects*; D014182:Transplantation, Autologous
D007155:Immunologic Factors; D000922:Immunotoxins; D007370:Interferon Type I